NCT05213910View on ClinicalTrials.gov

Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains

NACompletedINTERVENTIONAL

Enrollment

189

Participants

Timeline

Start Date

September 4, 2018

Primary Completion Date

November 15, 2021

Study Completion Date

November 15, 2021

Conditions

Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Lactichoc

dosage form: mix of 8 strains containing 1.2x10\^11 CFU frequency, and duration: 2 capsules/day during 10 days

OTHER

Stool sampling

3 stool samples are taken during the study (D0, D10 and D30)

Trial Locations (1)

Unknown

General practitioners or gastroenterologists consulting in french private offices, Paris

All Listed Sponsors

lead

PiLeJe

INDUSTRY

NCT05213910 - Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains | Biotech Hunter | Biotech Hunter